USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Washburn Therapeutics, Inc.
Address:
6743 Wilkins Ave.
Pittsburgh, PA
EIN:
300430358
DUNS:
803136758
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $335,770.00 2

Award List:

Development of Cytokine-Inhibiting Gels for Treating Chronic Wounds

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$185,770.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Chronic wounds developed by patients with diabetes are becoming an increasing burden for Americans and our health care system. Diabetic foot ulcers cost tens of thousands of dollars to treat and are the leading cause of lower extremity amputation. While there is… More

Reduction of Burn Progression and Scar Contracture with Cytokine-Neutralizing Gels

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
DOD
Principal Investigator:
Newell R. Washburn, President – (412) 908-1309
Abstract:
Washburn Therapeutics Inc. is developing biologically active gels that control inflammation by selectively neutralizing pro-inflammatory cytokines based on a technology being licensed exclusively by the company from Carnegie Mellon University. Preliminary results demonstrated that conjugates of… More